Skip to main content

Pharmacological interventions for sex offenders: A poor evidence base to guide practice: Commentary on… Cochrane Corner

  • Keith Rix

Although a significant proportion of prisoners and patients in secure hospitals are sex offenders and victim surveys reveal a high level of hidden sexual victimisation, the authors of this Cochrane review found only very limited support for pharmacological intervention with sex offenders. Given the nature and extent of the problem of sexual offending and the promise shown by new drugs, there is a need for clinical scientists, lawyers and ethicists to rise to the challenge of ascertaining the effectiveness and safety of drugs which are being used to treat sex offenders, some involuntarily, without the evidence base to justify confidence as to their effectiveness and safety.

Corresponding author
Professor Keith J. B. Rix, The Fermoy Unit, Queen Elizabeth Hospital, Gayton Road, King's Lynn PE30 4ET, UK. Email:
Hide All

See p. 360, this issue.

Declaration of Interest


Hide All
Ashman, L, Duggan, L (2008) Interventions for learning disabled sex offenders. Cochrane Database of Systematic Review, 1: CD003682 (doi:10.1002/14651858.CD003682.pub2).
Bancroft, J, Tennent, G, Loucas, K, et al (1974) The control of deviant sexual behaviour by drugs. 1. Behavioural changes following oestrogens and anti-androgens. British Journal of Psychiatry, 125: 310–5.
Bradford, JMW, Pawlak, A (1993) Effects of cyproterone acetate on sexual arousal patterns of paedophiles. Archives of Sexual Behavior, 22: 629–41.
Briken, P, Kafka, MP (2007) Pharmacological treatment for paraphilic patients and sexual offenders. Current Opinion in Psychiatry, 20: 609–13.
Briken, P, Müller, JL, Berner, W, et al (2017) Vom Scheitern einer Studie in Maßregelvollzugskrankenhäusern: Klinische Prüfung zum additiven Effekt von Triptorelin auf die Wirksamkeit von Psychotherapie [Failure of a study in forensic psychiatric hospitals: clinical trial to investigate the additive effect of triptorelin on the efficacy of psychotherapy]. Der Nervenarzt, 88: 480–5.
Cooper, AJ (1981) A placebo-controlled trial of the antiandrogen cyproterone acetate in deviant hypersexuality. Comprehensive Psychiatry, 22: 458–65.
Dennis, J, Huband, N, Khan, O, et al (2012) Psychological interventions for adults who have sexually offended or are at risk of offending. Cochrane Database of Systematic Reviews, 12: CD007507 (doi: 10.1002/14651858.CD007507.pub2).
Duggan, CF, Hollin, CR, Huband, N, et al (2013) A comparison of mentally disordered male offenders with and without a sexual offence: their characteristics and outcome. Sex Offender Treatment, 8: 18.
Eastman, N, Adshead, G, Fox, S, et al (2012) Forensic Psychiatry. Oxford University Press.
Fazal, S, Grann, M (2006) The population impact of severe mental illness on violent crime. American Journal of Psychiatry, 163: 1397–403.
Firestone, P, Bradford, JM, Greenberg, DM, et al (2000) The relationship of deviant sexual arousal and psychopathy in incest offenders, extrafamilial child molesters, and rapists. Journal of the American Academy of Psychiatry and Law, 28: 303–8.
Hanson, RK, Bussiere, MT (1998) Predicting relapse: a meta-analysis of sexual offender recidivism studies. Journal of Consulting and Clinical Psychology, 66: 348–62.
Hucker, S, Langevin, R, Bain, J (1988) A double blind trial of sex drive reducing medication in paedophiles. Sexual Abuse: A Journal of Research and Treatment, 1: 227–42.
Khan, O, Ferriter, M, Huband, N, et al (2015) Pharmacological interventions for those who have sexually offended or are at risk of offending. Cochrane Database of Systematic Reviews, 2: CD007989 (doi: 10.1002/14651858.CD007989.pub2).
Langevin, R, Paitich, D, Hucker, S, et al (1979) The effect of assertiveness training, Provera and sex of therapist in the treatment of genital exhibitionism. Journal of Behavior Therapy and Experimental Psychiatry, 10: 275–82.
McConaghy, N, Blaszczynski, A, Kidson, W (1988) Treatment of sex offenders with imaginal desensitization and/or medroxyprogesterone. Acta Psychiatrica Scandinavica, 77: 199206.
McEvoy, G (ed) (2017) AHFS Drug Information 2017. American Society of Health Information Pharmacists.
Prentky, RA, Lee, AFS, Knight, RA, et al (1997) Recidivism rates among child molesters and rapists: a methodological analysis. Law and Human Behavior, 21: 635–59.
Rösler, A, Witzum, E (1998) Treatment of men with paraphilia with a long-acting gonadotropin-releasing hormone. New England Journal of Medicine, 338: 416–22.
Taylor, PJ, Leese, M, Williams, D, et al (1998) Mental disorder and violence: a special (high security) hospital study. British Journal of Psychiatry, 172: 218–26.
Tennent, G, Bancroft, J, Cass, J (1974) The control of deviant sexual behaviour by drugs: a double-blind controlled study of benperidol, chlorpromazine and placebo. Archives of Sexual Behavior, 3: 261–71.
Turner, D, Basdekis-Jozsa, R, Briken, P (2013) Prescription of testosterone lowering medication for sex offender treatment in German forensic psychiatric institutions. Journal of Sexual Medicine, 10: 570–8.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Advances
  • ISSN: 2056-4678
  • EISSN: 2056-4686
  • URL: /core/journals/bjpsych-advances
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 79 *
Loading metrics...

Abstract views

Total abstract views: 108 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 25th May 2018. This data will be updated every 24 hours.

Pharmacological interventions for sex offenders: A poor evidence base to guide practice: Commentary on… Cochrane Corner

  • Keith Rix
Submit a response


No eLetters have been published for this article.


Reply to: Submit a response

Your details

Conflicting interests

Do you have any conflicting interests? *